Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Iran J Public Health ; 52(3): 662-664, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37124902
2.
Folia Med (Plovdiv) ; 65(3): 384-392, 2023 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-38351813

RESUMO

INTRODUCTION: One of the major obstetrical complications, affecting 2%-8% of all pregnancies, is preeclampsia. To predict the onset of preeclampsia, several methods have recently been put forth. The Fetal Medicine Foundation has developed combined screening that can identify the vast majority of women who will develop preeclampsia using a combination of maternal factors, obstetrical history, biochemical, and biophysical factors.


Assuntos
Pré-Eclâmpsia , Gravidez , Feminino , Humanos , Pré-Eclâmpsia/epidemiologia , Pré-Eclâmpsia/diagnóstico , Gestantes , Fator de Crescimento Placentário , Bulgária/epidemiologia , Biomarcadores
3.
Folia Med (Plovdiv) ; 64(3): 380-387, 2022 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-35856097

RESUMO

Despite being a physiological condition, human pregnancy is known to cause numerous complications that can endanger the life of the mother and the fetus alike. While the majority of complications are mostly limited within the peripartum period, more and more information is available about persistently higher short- and long-term cardiovascular risk after a pregnancy complicated by a hypertensive disorder. There is evidence that women after gestational hypertension or preeclampsia are more likely to develop arterial hypertension, coronary atherosclerosis, myocardial infarction, stroke, peripheral artery disease, and even diabetes mellitus and venous thromboembolism years after the target pregnancy. This has urged some authors to view hypertensive disorders of pregnancy as a "stress test" for the maternal organism that unmasks latent endothelial dysfunction. An explanation is sought in the presence of common risk factors and underlying pathological pathways with cardiovascular diseases, although a certain etiological mechanism for the development of hypertensive disorders in pregnancy has not been established yet. More attention is needed towards the follow-up of women after a hypertensive pregnancy as it could be an opportunity for early prevention of cardiovascular diseases.


Assuntos
Doenças Cardiovasculares , Hipertensão Induzida pela Gravidez , Hipertensão , Pré-Eclâmpsia , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Feminino , Humanos , Hipertensão/epidemiologia , Hipertensão Induzida pela Gravidez/epidemiologia , Pré-Eclâmpsia/epidemiologia , Gravidez , Fatores de Risco
4.
Cardiovasc J Afr ; 33(2): 65-73, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34546286

RESUMO

BACKGROUND: Pre-eclampsia and gestational hypertension are pregnancy-related disorders with major maternal cardiovascular implications later in life. OBJECTIVES: The aim of this study was to determine interleukin-6 levels in women with pre-eclampsia and gestational hypertension and in healthy pregnant controls, and to examine their correlations with characteristics of the women and echocardiographic findings. METHODS: The ELISA method was used to determine serum interleukin-6 in 36 women with gestational hypertension, 37 women with pre-eclampsia and 50 pregnant controls. The echocardiographic examination was performed according to current recommendations by the European Association of Cardiovascular Imaging and the American Society of Echocardiography. RESULTS: Mean serum interleukin-6 levels were 2.77 pg/ml in the controls, 5.08 pg/ml in the gestational hypertension group and 8.06 pg/ml in the pre-eclampsia group. A significant difference in these levels was present between the controls and both hypertensive groups, but not between the two hypertensive groups. Higher levels correlated with heart chamber enlargement and worse ventricular function. CONCLUSION: Interleukin-6 levels in gestational hypertension and pre-eclampsia were significantly elevated compared to those in healthy pregnancy. Higher levels also corresponded to echocardiographical changes.


Assuntos
Hipertensão Induzida pela Gravidez , Pré-Eclâmpsia , Pressão Sanguínea , Ecocardiografia , Feminino , Humanos , Hipertensão Induzida pela Gravidez/diagnóstico por imagem , Interleucina-6 , Pré-Eclâmpsia/diagnóstico por imagem , Gravidez
5.
Folia Med (Plovdiv) ; 63(2): 272-276, 2021 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-33932019

RESUMO

Mermaid syndrome or sirenomelia is an extremely rare congenital malformation with an incidence between 1.5 and 4.2 per 1,000,000 pregnancies. Association of mermaid syndrome with VACTERL-H syndrome is extremely rare, with only two cases reported so far in the literature. We present a new case of type I sirenomelia associated with VACTERL-H syndrome and review the relevant literature. A 15-year-old female patient was admitted to the Department of Pathological Pregnancy at St George University Hospital, Plovdiv with progredient abortion during her first pregnancy. She had low socioeconomic status, negative history of concomitant diseases and addictions. The patient avoided prophylactic intake of folic acid during her pregnancy. Prenatal ultrasound found a malformative fetus. Consequently, magnetic resonance imaging was performed which established the presence of hydrocephalus and defects in the lower part of the spine. These pathological findings indicated interruption of pregnancy at 20 weeks of gestation. The fetopathological examination found sirenomelia type I associated with myelomeningocele, hydrocephalus, anal imperforation, single umbilical artery, bilateral renal and ureteric agenesis, bladder agenesis, tracheo-esophageal fistula, agenesis of external genitals, monkey fold of the left palm of the hand, also known as VACTERL-H syndrome.Our case demonstrates that mermaid syndrome and VACTERL-H syndrome represent different manifestations of a single pathological process that results in disorders of the blastogenesis at different stages during embryonic development.


Assuntos
Ectromelia , Cardiopatias Congênitas , Hidrocefalia , Adolescente , Canal Anal/anormalidades , Anormalidades Cardiovasculares , Anormalidades do Sistema Digestório , Esôfago/anormalidades , Feminino , Doenças Genéticas Ligadas ao Cromossomo X , Cardiopatias Congênitas/complicações , Cardiopatias Congênitas/diagnóstico por imagem , Humanos , Rim/anormalidades , Deformidades Congênitas dos Membros , Anormalidades Musculoesqueléticas , Gravidez , Coluna Vertebral/anormalidades , Síndrome , Traqueia/anormalidades
6.
J Clin Med ; 10(2)2021 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-33450923

RESUMO

Endometrial cancer (EC) has been associated with an increased risk of cardiovascular disease, including atrial fibrillation (AF). We performed a prospective, case-controlled analysis among 310 Bulgarian women with new-onset, histologically confirmed EC, free of AF at the baseline survey, and women with normal (senile) endometrium/endometrial hyperplasia as a control group (n = 205). The risk of AF as well as relationship of adiponectin (APN) and high sensitivity C-reactive protein (hs-CRP) levels with AF in women with EC were calculated by Cox proportional hazards models. During the mean follow-up of 2.5 ± 0.5 years, new-onset AF had occurred in 11.7% of women with EC vs. 5.8% in the control group (p < 0.01). The risk of AF was highest in the first 6 months after new-onset EC, with an incidence rate ratio (IRR) of 1.19 (95% CI 1.10-1.29; p = 0.01). Women with EC, who were obese (body mass index (BMI) > 30 kg/m2) and younger (age < 60) were found to be more likely to develop AF (HR 1.95; 95% CI 1.18-3.32; p = 0.05). APN levels were not significantly associated with new-onset AF (95% CI 0.87-1.21; p = 0.063). However, the secondary analysis showed evidence of APN-AF association when adjusted for BMI (2.05; 95% CI 1.04-4.04; p = 0.037). We conclude that EC was significantly associated with the incidence of AF.

7.
Folia Med (Plovdiv) ; 63(4): 511-518, 2021 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-35851172

RESUMO

INTRODUCTION: Gestational hypertension is a less investigated hypertensive disorder of pregnancy than preeclampsia, but evidence exists of an unfavourable cardiovascular profile for women after such a pregnancy. AIM: To determine serum high-sensitivity C-reactive protein (hs-CRP) levels in women with preeclampsia, gestational hypertension, and in normotensive pregnancy in order to assess the cardiovascular implications and to examine its correlations with some characteristics of women. MATERIALS AND METHODS: Thirty-six women with gestational hypertension, thirty-seven with preeclampsia, and fifty maternal and gestational age-matched controls were included in a single-center prospective clinical-epidemiological study. Serum hs-CRP levels were determined using ELISA method. RESULTS: Significantly higher hs-CRP levels were found in the gestational hypertension group than in the controls (p=0.043), but not in the preeclampsia group (p=0.445). The levels between the two pathological groups did not differ significantly (p=0.247). Odds ratio for hs-CRP levels higher than the provided cut-off was 3.31 (95% CI 1.32-8.29) for the presence of gestational hypertension. In the normotensive pregnant women, the hs-CRP levels had a positive correlation with BSA, pre-pregnancy and current BMI, but such correlations were absent in the hypertensive groups. There were no correlations with the maternal or gestational age, current weight gain in any of the groups or with the highest detected blood pressure in the pathological groups. These levels did not differ according to gravidity, smoking status and smoking during pregnancy. CONCLUSIONS: Elevation of hs-CRP was more pronounced in women with gestational hypertension than in women with preeclampsia, which could indicate a different pathophysiological mechanism and a higher cardiovascular risk for those women.


Assuntos
Hipertensão Induzida pela Gravidez , Pré-Eclâmpsia , Pressão Sanguínea , Proteína C-Reativa/metabolismo , Feminino , Humanos , Gravidez , Gestantes , Estudos Prospectivos
8.
Int. j. morphol ; 38(3): 793-798, June 2020. graf
Artigo em Inglês | LILACS | ID: biblio-1098321

RESUMO

Sirenomelia or mermaid syndrome is an extremely rare congenital lethal malformation with a frequency between 1.5 and 4.2 per 1 000 000 pregnancies.The association of sirenomelia with the VACTERL association is very rare, with twenty cases reported in the literature and only two cases with VACTERL-H. We present two cases of sirenomelia, type I and type II associated with VACTERL-H and VACTERL syndromes and we review the literature. First time pregnancy women aged 15 and 40 years, without harmful habits and diseases, where between 25-27 gestational week (GW) the prenatal study identifies malformative fetus and the pregnancy is interrupted by medical evidence. The fetopathological examination in the first case identified sirenomelia type I associated with myelomeningocele, hydrocephalus, anal imperforation, single umbilical artery, bilateral renal agenesis, ureteral and bladder agenesis, tracheo-esophageal fistule, agenesis of external genitals, monkey fold of the left palm of the hand - VACTERL-H. In the second case, where genetic testing is normal, sirenomelia type II associated with agenesis of external genitalia, anal imperforation, myelomeningocele, dolichocrania, macroglossia, low set ears, left preauricular skin tag, long philtrum, lung hypoplasia, split cadiac apex, single umbilicalis artery, blind end colon, hepatomegaly, accessory spleen, polycystic horseshoe kidney, uterine and vaginal agenesis, presence of two ovaries and duodenal stenosis - VACTERL association. This two cases, lead us to believe that sirenomelia and the VACTERL association are probably different manifestations of a pathogenetic process leading to disorders of blastogenesis at different levels during embryonic development.


La sirenomelia es una malformación congénita y excepcionalmente rara, con una frecuencia entre 1,5 y 4,2 en un millón de embarazos. La combinación de la sirenomelia con el síndrome de VACTERL es igualmente rara. La literatura especializada informa sobre la existencia de una veintena de casos solamente; en lo que respecta a su asociación con el síndrome de VACTERL-H se conocen solo dos casos. Luego de realizar una revisión de la literatura presentamos dos casos de sirenomelia asociada con los síndromes de VACTERL-H y de VACTERL En el estudio se analizaron los primeros embarazos de dos mujeres, edad de 15 y de 40 años, respectivamente, ambas mujeres completamente sanas y sin hábitos viciosos. Entre la vigésima quinta y la vigésima séptima semana gestacional (SG) del embarazo ambas mujeres, el análisis prenatal comprueba la existencia de malformación del feto debido a lo cual los embarazos fueron interrumpidos por prescripción médica. El análisis fetopatológico del primer caso comprueba la existencia de sirenomelia de tipo I asociada con mielomeningocele, hidrocefalia, atresia anal, arteria umbilical única, agenesia bilateral de los riñones y de los ureteres que transportan la orina desde los riñones hasta la vejiga, fístula traqueoesofágica, agenesia de los órganos genitales externos, línea simiesca en la palma de la mano izquierda - VACTERLH. En el segundo caso, en que el análisis genético ha resultado normal, se observó la presencia de sirenomelia de tipo II asociada con agenesia de los órganos genitales externos, atresia anal, mielomeningocele, dolicocrania, macroglosia, orejas bajas, filtrum alargado, hipoplasia pulmonar, ápice cardíaco escindido, arteria umbilical única, colon terminado en ciego, bazo accesorio, poliquistosis renal, riñón en herradura, agenesia vaginal y de útero, presencia de dos ovarios y estenosis duodenal - VACTERL asociación. Los dos casos investigados permiten llegar a la conclusión de que la sirenomelia y su combinación con el síndrome de VACTERL probablemente sean manifestaciones diferentes de un proceso patogenético que conlleva la alteración de la blastogénesis en distintos niveles durante el proceso del desarrollo embrionario.


Assuntos
Humanos , Feminino , Gravidez , Adolescente , Adulto , Anormalidades Múltiplas , Ectromelia/complicações , Ectromelia/diagnóstico , Doenças Fetais/diagnóstico , Canal Anal/anormalidades , Síndrome , Traqueia/anormalidades , Evolução Fatal , Esôfago/anormalidades , Rim/anormalidades
9.
Folia Med (Plovdiv) ; 58(2): 108-14, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27552787

RESUMO

UNLABELLED: Vulvovaginal candidiasis is the second most common cause of vaginitis worldwide (after bacterial candidiasis). Maternal vulvovaginal candidiasis is a major risk factor for Candida colonization and infection of the infant where prognosis depends on different predisposing factors. The aim of this study was to determine the incidence and the etiological structure of vulvovaginal candidiasis in pregnant women and its impact on Candida colonization of newborns. MATERIALS AND METHODS: Samples of vaginal secretions from 80 healthy pregnant women who were clinically suspicious for Candida vaginitis were collected within 48 hours before delivery. Samples for probable Candida colonization from the oral mucosa and feces were collected from their newborns within 47-72 hours after birth. Samples were plated on Sabouraud agar, followed by species identification by API Candida yeast assay. RESULTS: Twenty-three (28.75 ± 5.06%) of the evaluated pregnant women were positive for Candida spp. Positive samples for Candida colonization were found in 18 (22.22 ± 4.62%) of the examined 81 newborns (one pair of twins) from mothers who were clinically suspicious for vaginal candidiasis. Isolates of the newborns were 100% identical to those of the mothers' vaginal secretion. Candida albicans was the predominant species identified in the pregnant women (91.67 ± 0.06%) and in the neonates (83.33±8.78%).


Assuntos
Candidíase Vulvovaginal/epidemiologia , Portador Sadio/epidemiologia , Transmissão Vertical de Doenças Infecciosas/estatística & dados numéricos , Complicações Infecciosas na Gravidez/epidemiologia , Adolescente , Adulto , Candida albicans/isolamento & purificação , Candidíase Vulvovaginal/microbiologia , Candidíase Vulvovaginal/transmissão , Portador Sadio/microbiologia , Portador Sadio/transmissão , Fezes/microbiologia , Feminino , Humanos , Incidência , Recém-Nascido , Boca/microbiologia , Gravidez , Adulto Jovem
10.
Braz. arch. biol. technol ; 58(5): 757-764, tab, graf
Artigo em Inglês | LILACS | ID: lil-764491

RESUMO

ABSTRACTThe present study aimed to investigate the histological alterations in common carp gills caused by a fosetyl-Al and fenamidone based fungicide tested in laboratory conditions at 30, 38 and 50 mg/L concentration. In general, all the tested concentrations activated compensatory-adaptive mechanisms, which caused pathological changes in the fish gills. Results showed different histological alterations in the gill structure, which included lamellar lifting, edema, proliferation of the glandular cells and epithelium, covering the gill filament, fusion and degenerative alterations. Blood circulatory system showed vasodilatation of the secondary lamellae and aneurysms. Overall, there was enhancement of the gill histological changes, which was dose-dependent, i.e., proportional to the increasing fungicide concentrations. Thus, based on the results, it was concluded that the histological alterations in common carp gills could be applied as possible biomarkers in risk assessment and monitoring programs for pesticide contamination of aquatic ecosystems.

12.
Expert Opin Pharmacother ; 9(11): 1839-44, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18627323

RESUMO

OBJECTIVE: To compare the effects of two monophasic oral contraceptives upon coagulation, fibrinolysis and the system of natural inhibitors (anticoagulant pathways) in Bulgarian women. METHODS: This prospective, open clinical study lasted 12 months and included 70 women, divided into two equal groups of 35 each. The women from group A received a contraceptive containing 20 microg ethinylestradiol/75 microg gestodene. The women from group B received a contraceptive containing 30 microg ethinylestradio l/75 microg gestodene. At the beginning and again at the end of the study, the following values were determined: prothrombin time (PT), activated partial thromboplastic time (aPTT), thrombin time (TT), fibrinogen (F), Factor VII (FVII), Factor X (FX), plasminogen, alpha 2-antiplasmin, tissue-type plasminogen activator (t-PA), D-dimers, protein C (Pr C), total Protein S (TPr S), antithrombin III (AT III) and heparin Cofactor II (HC II). RESULTS: We did not find any statistically significant differences in the global tests of hemostasis (PT, aPTT, TT) in either group compared with the baseline values. At the end of the study there was an increase in the levels of fibrinogen, FX, PrC and H II, and also diminution of t-PA in both groups in comparison with the baseline values. At the end of the study the activity of FVII, alpha2-antiplasmin and AT III was elevated only in group B. Although certain alterations in hemostasis parameters were observed, all of them were within the reference range. We did not observe or suspect any cases of vascular, thrombotic or other incidence in the observed groups of 840 cycles of hormonal contraception over the 12-month period. CONCLUSION: There is an increase in both procoagulant and fibrinolytic activity when using low-dose gestodene containing monophasic oral contraceptives. This can be interpreted as a shift to a higher equilibrium. There is no need for screening for thrombofilia in healthy, non-obese, non-smoking Bulgarian females, aged between 18 to 35 years, without a personal or family history of thrombotic diseases, before starting on third generation oral contraceptive with gestodene.


Assuntos
Anticoncepcionais Orais Combinados/efeitos adversos , Etinilestradiol/efeitos adversos , Hemostasia/efeitos dos fármacos , Norpregnenos/efeitos adversos , Adolescente , Adulto , Coagulação Sanguínea/efeitos dos fármacos , Testes de Coagulação Sanguínea , Bulgária , Anticoncepcionais Orais Combinados/administração & dosagem , Anticoncepcionais Orais Sintéticos/administração & dosagem , Anticoncepcionais Orais Sintéticos/efeitos adversos , Relação Dose-Resposta a Droga , Etinilestradiol/administração & dosagem , Feminino , Fibrinólise/efeitos dos fármacos , Humanos , Norpregnenos/administração & dosagem , Estudos Prospectivos
13.
Folia Med (Plovdiv) ; 48(2): 5-10, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17408070

RESUMO

The present literature review includes the data available from 1995 to 2005 about the biological functions of estrogen receptors (ERs) and their role in tumorigenesis. The domain organisation,and cell and tissue localization of two estrogen receptors are described. The article reviews the well known function of these receptors as transcription factors and their less familiar extracellular "non-genome" effects. Because of their stimulating effect on cell proliferation estrogens are supposed to actively participate in the genesis and development of some malignant conditions. We draw particular attention to the significance these estrogen receptors have for the onset and development of tumors outside the reproductive system. Knowledge of the receptor mechanisms of estrogenic action may enhance the diagnostic and therapeutic opportunities to treat a wide range of neoplastic lesions.


Assuntos
Estrogênios/fisiologia , Receptores de Estrogênio/fisiologia , Apoptose , Proliferação de Células , Estrogênios/metabolismo , Humanos , Neoplasias/genética , Neoplasias/metabolismo , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Transcrição Gênica/fisiologia
14.
Eur J Obstet Gynecol Reprod Biol ; 119(2): 185-8, 2005 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-15808377

RESUMO

OBJECTIVES: (1) To study the changes in the haemostatic variables during normal pregnancy, and (2) to compare them with the corresponding variables in a control group of nonpregnant women. SETTING: University Hospital. SUBJECTS: The study involves two groups of women: pregnant women (in 35th-40th gestational weeks (GW)) (N = 35) and a control group of nonpregnant women (N = 35). METHODS: We examined the global tests, the variables relating to coagulation and fibrinolysis and the group of natural inhibitors of coagulation, and compared them between the two groups. RESULTS: The pregnant women had statistically significantly higher values for: prothrombin time (PT) (P < 0.0001), thrombin time (TT) (P < 0.0001), fibrinogen (P < 0.0001), activity of factor VII (P < 0.0001), factor X (P < 0.0001) and alpha2-antiplasmin (P < 0.002), plasma concentration of D-dimer (plsDD) (P < 0.0001) and activity of heparin cofactor II (HCII) (P < 0.002). They had statistically significantly lower activity of protein C (PrC) (P < 0.0001) and of total protein S (TPrS) (P < 0.0001). CONCLUSION: During normal pregnancy the activation of coagulation is counterbalanced by the activation of fibrinolysis, which maintains the haemostatic balance.


Assuntos
Hemostasia , Gravidez/sangue , Fator VII/análise , Fator X/análise , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio/análise , Fibrinogênio/análise , Idade Gestacional , Cofator II da Heparina/análise , História do Século XVI , Humanos , Proteína C/análise , Proteína S/análise , Tempo de Protrombina , Valores de Referência , Tempo de Trombina , alfa 2-Antiplasmina/análise
16.
Obes Surg ; 14(9): 1280-2, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15527649

RESUMO

A wide range of operations are used today for morbid obesity. Adjustable gastric banding (AGB) is one of the most widespread. Numerous complications after AGB are known, namely gastric perforation, band slippage, penetration of the band into stomach, port disconnection, port-site infection, etc. The authors present a case of small bowel obstruction caused by the intra-abdominal silicone tube of the gastric band in a woman with AGB performed 9 years before, with a very good result and considerable weight loss. She was operated as an emergency, and part of the terminal ileum was found incarcerated around and between the silicone tube and the anterior abdominal wall. Bowel resection for intestinal necrosis, with terminal ileostomy, was performed, followed 1 month later by an end-to-end ileo-ileal anastomosis. The patient recovered without sequelae.


Assuntos
Gastroplastia/efeitos adversos , Obstrução Intestinal/etiologia , Abdome Agudo/etiologia , Adulto , Feminino , Humanos , Ileostomia , Obstrução Intestinal/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...